Jean-pierre Sommadossi - Net Worth and Insider Trading

Jean-pierre Sommadossi Net Worth

The estimated net worth of Jean-pierre Sommadossi is at least $24 Million dollars as of 2024-05-12. Jean-pierre Sommadossi is the President, CEO, and Chairman of Atea Pharmaceuticals Inc and owns about 6,041,557 shares of Atea Pharmaceuticals Inc (AVIR) stock worth over $24 Million. Details can be seen in Jean-pierre Sommadossi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jean-pierre Sommadossi has not made any transactions after 2024-02-01 and currently still holds the listed stock(s).

Transaction Summary of Jean-pierre Sommadossi

Jean-pierre Sommadossi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jean-pierre Sommadossi owns 3 companies in total, including Kezar Life Sciences Inc (KZR) , Atea Pharmaceuticals Inc (AVIR) , and ABG Acquisition Corp I (ABGI) .

Click here to see the complete history of Jean-pierre Sommadossi’s form 4 insider trades.

Insider Ownership Summary of Jean-pierre Sommadossi

Ticker	Comapny	Transaction Date	Type of Owner
KZR	Kezar Life Sciences Inc	2018-06-20	director
AVIR	Atea Pharmaceuticals Inc	2024-02-01	director & 10 percent owner & President & CEO & and Chairman
ABGI	ABG Acquisition Corp I	2021-02-16	director

Jean-pierre Sommadossi Latest Holdings Summary

Jean-pierre Sommadossi currently owns a total of 1 stock. Jean-pierre Sommadossi owns 6,041,557 shares of Atea Pharmaceuticals Inc (AVIR) as of February 1, 2024, with a value of $24 Million.

Latest Holdings of Jean-pierre Sommadossi

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
AVIR	Atea Pharmaceuticals Inc	2024-02-01	6,041,557	3.89	23,501,657

Holding Weightings of Jean-pierre Sommadossi

Jean-pierre Sommadossi Form 4 Trading Tracker

According to the SEC Form 4 filings, Jean-pierre Sommadossi has made a total of 1 transactions in Atea Pharmaceuticals Inc (AVIR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Atea Pharmaceuticals Inc is the sale of 56,910 shares on February 1, 2024, which brought Jean-pierre Sommadossi around $219,104.

Insider Trading History of Jean-pierre Sommadossi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jean-pierre Sommadossi Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jean-pierre Sommadossi Ownership Network

Ownership Network List of Jean-pierre Sommadossi

No Data

Ownership Network Relation of Jean-pierre Sommadossi

Jean-pierre Sommadossi Owned Company Details

What does Kezar Life Sciences Inc do?

Who are the key executives at Kezar Life Sciences Inc?

Jean-pierre Sommadossi is the director of Kezar Life Sciences Inc. Other key executives at Kezar Life Sciences Inc include 10 percent owner Morningside Venture Investments Ltd , Chief Business Officer Nicholas Michael Mordwinkin , and 10 percent owner Equal Talent Investments Ltd .

Kezar Life Sciences Inc (KZR) Insider Trades Summary

Over the past 18 months, Jean-pierre Sommadossi made no insider transaction in Kezar Life Sciences Inc (KZR). Other recent insider transactions involving Kezar Life Sciences Inc (KZR) include a net sale of 508,747 shares made by Morningside Venture Investments Ltd ,

In summary, during the past 3 months, insiders sold 0 shares of Kezar Life Sciences Inc (KZR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 508,747 shares of Kezar Life Sciences Inc (KZR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 508,747 shares.

Kezar Life Sciences Inc (KZR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kezar Life Sciences Inc Insider Transactions

No Available Data

What does Atea Pharmaceuticals Inc do?

Who are the key executives at Atea Pharmaceuticals Inc?

Jean-pierre Sommadossi is the director & 10 percent owner & President & CEO & and Chairman of Atea Pharmaceuticals Inc. Other key executives at Atea Pharmaceuticals Inc include See Remarks Andrea Corcoran , See Remarks Wayne Foster , and Acting Chief Medical Officer Maria Arantxa Horga .

Atea Pharmaceuticals Inc (AVIR) Insider Trades Summary

Over the past 18 months, Jean-pierre Sommadossi made 1 insider transaction in Atea Pharmaceuticals Inc (AVIR) with a net sale of 56,910. Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 41,666 shares made by Franklin M Berger , a net sale of 15,870 shares made by Maria Arantxa Horga , and a net sale of 15,843 shares made by Andrea Corcoran .

In summary, during the past 3 months, insiders sold 0 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 168,614 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 168,614 shares.

Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Atea Pharmaceuticals Inc Insider Transactions

No Available Data

What does ABG Acquisition Corp I do?

Who are the key executives at ABG Acquisition Corp I?

Jean-pierre Sommadossi is the director of ABG Acquisition Corp I. Other key executives at ABG Acquisition Corp I include director & Chief Financial Officer Kevin C Reilly , director & 10 percent owner & Chief Executive Officer Fan Yu , and 10 percent owner Abg Acquisition Holdings I Llc .

ABG Acquisition Corp I (ABGI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ABG Acquisition Corp I (ABGI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ABG Acquisition Corp I (ABGI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ABG Acquisition Corp I (ABGI)'s detailed insider trading history can be found in Insider Trading Tracker table.

ABG Acquisition Corp I Insider Transactions

No Available Data

Jean-pierre Sommadossi Mailing Address

Above is the net worth, insider trading, and ownership report for Jean-pierre Sommadossi. You might contact Jean-pierre Sommadossi via mailing address: 125 Summer Street, 16th Floor, Boston Ma 02110.

Discussions on Jean-pierre Sommadossi

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.